| Dr Jeffrey B Perrin, MD | |
|
11130 Capital Blvd, Wake Forest, NC 27587-4513 | |
| (919) 488-4094 | |
| (919) 488-4096 |
| Full Name | Dr Jeffrey B Perrin |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 11130 Capital Blvd, Wake Forest, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053371070 | NPI | - | NPPES |
| 89126WA | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 200000580 (North Carolina) | Primary |
| Entity Name | Private Diagnostic Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
Late-breaking data presented at TCT 2007, the scientific symposium of the Cardiovascular Research Foundation (CRF), show that the use of the anticoagulant bivalirudin following angioplasty in heart attack patients reduces net adverse clinical events by 24 percent compared to the standard treatment, and significantly reduces major bleeding that occurs after angioplasty by 40 percent.
Now on Kaiser Health News' blog, Christian Torres reports on the latest numbers regarding young adults' health insurance coverage: "More than 3 million young adults have gained insurance coverage under the health law, according to the latest government estimate. Obama administration officials touted the benefit Tuesday as an example of how the law is making a difference."
A study conducted at the University of Colorado and National Institutes of Health, USA, has revealed that the resistance developed by newly emerging variants of SARS-CoV-2 against host interferon responses could serve as a potential driving force for viral evolution.
With the launch of MEDI PORT, C PORT Solutions is the world's first company to converge all forms of communication and collaboration with patient data, medical applications, and existing healthcare technologies so all healthcare professionals can diagnose or treat a patient with the highest level of care regardless of the healthcare professional's location.
Pateamine A (PatA), a natural product first isolated from marine sponges, has attracted considerable attention as a potential anti-cancer agent, and now a new activity has been found for it, which may reveal yet another anti-cancer mechanism. That's the assessment of Daniel Romo, a Texas A&M chemistry professor, and his colleagues at Johns Hopkins University who are pioneers in research involving this novel marine natural product.
› Verified 8 days ago
| Entity Name | Raleigh Pediatric Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508941535 PECOS PAC ID: 5991939837 Enrollment ID: O20131009001204 |
News Archive
Late-breaking data presented at TCT 2007, the scientific symposium of the Cardiovascular Research Foundation (CRF), show that the use of the anticoagulant bivalirudin following angioplasty in heart attack patients reduces net adverse clinical events by 24 percent compared to the standard treatment, and significantly reduces major bleeding that occurs after angioplasty by 40 percent.
Now on Kaiser Health News' blog, Christian Torres reports on the latest numbers regarding young adults' health insurance coverage: "More than 3 million young adults have gained insurance coverage under the health law, according to the latest government estimate. Obama administration officials touted the benefit Tuesday as an example of how the law is making a difference."
A study conducted at the University of Colorado and National Institutes of Health, USA, has revealed that the resistance developed by newly emerging variants of SARS-CoV-2 against host interferon responses could serve as a potential driving force for viral evolution.
With the launch of MEDI PORT, C PORT Solutions is the world's first company to converge all forms of communication and collaboration with patient data, medical applications, and existing healthcare technologies so all healthcare professionals can diagnose or treat a patient with the highest level of care regardless of the healthcare professional's location.
Pateamine A (PatA), a natural product first isolated from marine sponges, has attracted considerable attention as a potential anti-cancer agent, and now a new activity has been found for it, which may reveal yet another anti-cancer mechanism. That's the assessment of Daniel Romo, a Texas A&M chemistry professor, and his colleagues at Johns Hopkins University who are pioneers in research involving this novel marine natural product.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey B Perrin, MD 260 Horizon Dr, Raleigh, NC 27615-4922 Ph: (919) 488-0015 | Dr Jeffrey B Perrin, MD 11130 Capital Blvd, Wake Forest, NC 27587-4513 Ph: (919) 488-4094 |
News Archive
Late-breaking data presented at TCT 2007, the scientific symposium of the Cardiovascular Research Foundation (CRF), show that the use of the anticoagulant bivalirudin following angioplasty in heart attack patients reduces net adverse clinical events by 24 percent compared to the standard treatment, and significantly reduces major bleeding that occurs after angioplasty by 40 percent.
Now on Kaiser Health News' blog, Christian Torres reports on the latest numbers regarding young adults' health insurance coverage: "More than 3 million young adults have gained insurance coverage under the health law, according to the latest government estimate. Obama administration officials touted the benefit Tuesday as an example of how the law is making a difference."
A study conducted at the University of Colorado and National Institutes of Health, USA, has revealed that the resistance developed by newly emerging variants of SARS-CoV-2 against host interferon responses could serve as a potential driving force for viral evolution.
With the launch of MEDI PORT, C PORT Solutions is the world's first company to converge all forms of communication and collaboration with patient data, medical applications, and existing healthcare technologies so all healthcare professionals can diagnose or treat a patient with the highest level of care regardless of the healthcare professional's location.
Pateamine A (PatA), a natural product first isolated from marine sponges, has attracted considerable attention as a potential anti-cancer agent, and now a new activity has been found for it, which may reveal yet another anti-cancer mechanism. That's the assessment of Daniel Romo, a Texas A&M chemistry professor, and his colleagues at Johns Hopkins University who are pioneers in research involving this novel marine natural product.
› Verified 8 days ago
Dr. Aarthi S Agaram, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1655 Wake Dr Unit 101, Wake Forest, NC 27587 Phone: 919-556-4779 Fax: 919-556-5277 | |
Sarah Young Gessner, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1655 Wake Dr, Suite 101, Wake Forest, NC 27587 Phone: 919-556-4779 Fax: 919-556-5277 | |
Dr. Christian Nechyba, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3000 Rogers Rd Ste 210, Wake Forest, NC 27587 Phone: 919-385-2120 Fax: 919-385-2144 | |
Heather Braddock Acevedo, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1655 Wake Dr Unit 101, Wake Forest, NC 27587 Phone: 919-556-4779 Fax: 919-556-5277 | |
Dr. Dirk Hamp, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 11130 Capital Blvd, Wake Forest, NC 27587 Phone: 919-488-4094 Fax: 919-488-4096 | |
Dr. James M Poole, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11130 Capital Blvd, Wake Forest, NC 27587 Phone: 919-488-4094 Fax: 919-488-4096 |